OptimizeRx Corp - 8-K Filing
OptimizeRx Corp entered into a $35 million credit agreement with Fifth Third Bank on May 7, 2026, consisting of a $25 million term loan and a $10 million revolving facility. The proceeds were used to refinance the company's existing October 2023 Blue Torch Finance debt, pay fees, repurchase stock (as permitted), and for working capital and general corporate purposes. (Items: 1.01 Entry into a Material Definitive Agreement, 1.02 Termination of a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant)
Tickers: $OPRX